Status:
WITHDRAWN
Oral Probiotics to Allergic Pregnant Mother and Their Offspring to Prevent Allergic Disease
Lead Sponsor:
China Medical University Hospital
Conditions:
Allergic Diseases
Eligibility:
All Genders
Phase:
NA
Brief Summary
The aim of the study is first to detect the difference of the intestinal microbiome between allergic pregnant mother and the non-allergic pregnant mother using the next generation sequence, all postna...
Detailed Description
Allergic diseases are the largest group of non-communicable diseases (NCD) with an increasing prevalence in both the developed and developing world. There are significant bodies of research trying to ...
Eligibility Criteria
Inclusion
- An adult pregnant mother who is over 20 years old and has a history of asthma or eczema or allergic rhinitis who is exercising autonomous consent.
- Pregnant women over 20 years old without allergies.
- Infants ≧ 37 weeks gestational age.
Exclusion
- Under 20 years old.
- Pregnant mothers and babies with congenital immune diseases.
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03873792
Start Date
October 1 2018
End Date
December 31 2021
Last Update
March 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pediatrics, Children Hospital, China Medical University
Taichung, Taiwan, 404